Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

76 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Controversies in the use of beta blockers in heart failure.
Chavey WE 2nd, Bleske BE, Nicklas JM. Chavey WE 2nd, et al. Among authors: nicklas jm. Congest Heart Fail. 2003 Sep-Oct;9(5):255-62. doi: 10.1111/j.1527-5299.2003.00294.x. Congest Heart Fail. 2003. PMID: 14564144 Review.
Neutral effect on markers of heart failure, inflammation, endothelial activation and function, and vagal tone after high-dose HMG-CoA reductase inhibition in non-diabetic patients with non-ischemic cardiomyopathy and average low-density lipoprotein level.
Bleske BE, Nicklas JM, Bard RL, Brook RD, Gurbel PA, Bliden KP, Rajagopalan S, Pitt B. Bleske BE, et al. Among authors: nicklas jm. J Am Coll Cardiol. 2006 Jan 17;47(2):338-41. doi: 10.1016/j.jacc.2005.06.087. Epub 2005 Dec 20. J Am Coll Cardiol. 2006. PMID: 16412857 Clinical Trial.
76 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page